Moderna Announces Switzerland Exercises Its Option To Purchase 7M Additional Doses Of Moderna’s COVID-19 Booster Vaccine In 2022
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Swiss Federal Government has exercised its option to purchase an